Literature DB >> 27656663

Data on amyloid precursor protein accumulation, spontaneous physical activity, and motor learning after traumatic brain injury in the triple-transgenic mouse model of Alzheimer׳s disease.

Yasushi Kishimoto1, Hajime Shishido2, Mayumi Sawanishi1, Yasunori Toyota2, Masaki Ueno3, Takashi Kubota1, Yutaka Kirino1, Takashi Tamiya2, Nobuyuki Kawai4.   

Abstract

This data article contains supporting information regarding the research article entitled "Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer׳s disease" (H. Shishido, Y. Kishimoto, N. Kawai, Y. Toyota, M. Ueno, T. Kubota, Y. Kirino, T. Tamiya, 2016) [1]. Triple-transgenic (3×Tg)-Alzheimer׳s disease (AD) model mice exhibited significantly poorer spatial learning than sham-treated 3×Tg-AD mice 28 days after traumatic brain injury (TBI). Correspondingly, amyloid-β (Aβ) deposition within the hippocampus was significantly greater in 3×Tg-AD mice 28 days after TBI. However, data regarding the short-term and long-term influences of TBI on amyloid precursor protein (APP) accumulation in AD model mice remain limited. Furthermore, there is little data showing whether physical activity and motor learning are affected by TBI in AD model mice. Here, we provide immunocytochemistry data confirming that TBI induces significant increases in APP accumulation in 3×Tg-AD mice at both 7 days and 28 days after TBI. Furthermore, 3×Tg-AD model mice exhibit a reduced ability to acquire conditioned responses (CRs) during delay eyeblink conditioning compared to sham-treated 3×Tg-AD model mice 28 days after TBI. However, physical activity and motor performance are not significantly changed in TBI-treated 3×Tg-AD model mice.

Entities:  

Keywords:  AD, Alzheimer׳s disease; ANOVA, analysis of variance; APP, amyloid precursor protein; Amyloid precursor protein; CR, conditioned response; CS, conditioned stimulus; Eyeblink conditioning; Rotarod test; Spontaneous physical activity; TBI, traumatic brain injury; Traumatic brain injury; US, unconditioned stimulus

Year:  2016        PMID: 27656663      PMCID: PMC5021762          DOI: 10.1016/j.dib.2016.08.041

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the data These data describe specific behavioral and histological changes that occur in an Alzheimer׳s disease (AD) mouse model after traumatic brain injury (TBI), which may serve as a reference for other researchers interested in examining neurodegeneration after TBI in AD. These data serve as a fundamental and useful resource for other researchers that may seek to describe the progression of AD after brain injury; these data may stimulate further study of the mechanism of neurodegeneration that occurs after TBI in AD. This dataset also offers basic information regarding the use of classical eyeblink conditioning after TBI in an AD mouse model, which may be useful to other researchers in the development of future experiments.

Data

We first examined whether traumatic brain injury (TBI) induces amyloid precursor protein (APP) accumulation in the triple-transgenic AD-model (3×Tg-AD) mouse hippocampus (Fig. 1). Next, we assessed the short-term and long-term effects of TBI on spontaneous physical activity, motor coordination, and motor learning in 3×Tg-AD mice (Fig. 2, Fig. 3).
Fig. 1

Data showing amyloid precursor protein (APP) accumulation in the 3×Tg-Alzheimer׳s disease (AD) model mouse hippocampus after traumatic brain injury (TBI). (A) Images demonstrate axonal immunoreactivity for APP in the hippocampal commissure at 7 days or 28 days after TBI. Scale bars: 100 μm. (B) Quantification of hippocampal APP accumulation. The presence of APP (expressed as the percentage of the area occupied by APP-immunopositive deposition in the ipsilateral hippocampus) was assessed using the ImageJ analysis system (National Institute of Health, Bethesda, MD, USA). APP accumulation was significantly greater in TBI-treated 3×Tg-AD (closed bar) mouse hippocampus both 7 days and 28 days after injury. **p<0.01, *p<0.05 relative to the corresponding sham-operated control group (open bar).

Fig. 2

Data showing spontaneous physical activity (SPA) measures in traumatic brain injury (TBI)-treated 3×Tg-Alzheimer׳s disease (AD) model mice. (A, B) SPA was evaluated in TBI-treated (closed bar) and sham-treated 3×Tg-AD model (open bar) mice at 7 days (A) or 28 days (B) after TBI (n=7 in each group). Six separate parameters of spontaneous behavior (distance traveled, walking, jumping, rearing, hanging, and stretching) were evaluated for 3 h in the home cage. There were no significance differences between sham-operated and TBI-treated 3×Tg-AD model mice on any of the behavioral measures.

Fig. 3

Data showing motor coordination and motor learning after traumatic brain injury (TBI) as assessed by the rotarod and delay eyeblink conditioning tasks, respectively. (A, B) 3×Tg-Alzheimer׳s disease (AD) mice (n=14) were equally assigned to the sham-operated or TBI-treated groups (n=7 per group), and then were subjected to the rotarod test. (A) There was no significant difference in rotarod performance between sham-operated 3×Tg-AD mice and TBI-treated mice at 7 days after injury. Analysis of variance (ANOVA) revealed no significant interaction effects between sessions and groups [p=0.68; F(4, 48)=0.571] and no significant group effect [p=0.371; F(1, 12)=0.870]. (B) There was also no significant difference in rotarod performance between sham-operated 3×Tg-AD mice and TBI-treated mice at 28 days after injury. ANOVA revealed no significant interaction effects between sessions and groups [p=0.61; F(4, 48)=0.683] and no significant group effect [p=0.98; F(1, 12)=0.00058]. (C, D) 3×Tg-AD mice (n=14) were equally assigned to sham-operated or TBI-treated groups (n=7 per group), and then were subjected to the delay eyeblink conditioning task. (C) There were no significant differences in the ability to acquire the conditioned response (CR) during the 7-day sessions between the 2 groups at 7 days after TBI. ANOVA revealed no significant interaction effects between sessions and groups [p=0.29; F(6, 72)=0.436] and no significant group effect [p=0.492; F(1, 12)=0.500]. (D) In contrast, there were significant differences in the ability to acquire the CR between the 2 groups at 28 days after TBI. ANOVA revealed no significant interaction effects between sessions and groups [p=0.91; F(6, 72)=0.336], but a significant group effect was observed [p=0.023; F(1, 12)=6.755]. However, a post hoc Bonferroni test revealed no significant differences between the two groups on any day. *p<0.05 relative to the corresponding sham-operated control group.

Experimental design, materials and methods

Animals

Behavioral and histological data were obtained from 5- to 7-month-old 3×Tg-AD mice (25–30 g) [2].

Traumatic brain injury

3×Tg-AD mice were subjected to a sham operation or TBI using a weight-drop method [1]. We evaluated APP accumulation in the hippocampus of these mice at either 7 or 28 days after injury. A second group of 3×Tg-AD mice was also subjected to a sham operation or TBI, but behavioral measures were alternately collected at either 7 days or 28 days after injury.

Antibody staining

APP accumulation was examined using immunostaining with anti-APP polyclonal antibody (1:1000; AnaSpec, Fermont, CA). Briefly, sections were subjected to an antigen retrieval step by immersing the sections in 90% formic acid for 10 min before immunohistochemistry for Aβ. Sections were washed in diluted water, and endogenous peroxidases were quenched using a freshly prepared mixture of methanol (150 ml) plus hydrogen peroxide (33%, 1.5 ml) for 30 min and 2% normal goat serum in phosphate-buffered saline (PBS) with 0.1% Tween-20 for 30 min. Sections were then incubated overnight with a polyclonal antibody to APP at 37 °C. Sections then were rinsed five times for 5 min each with PBS with 0.1% Tween-20, and then incubated with peroxidase-labeled anti-rabbit antibody (Histofine Simple Stain Max PO, Nichirei, Japan) for 30 min at 37 °C. Peroxidase activity was detected with diaminobenzidine (DAB, Nichirei, Japan) for visualization. Sections were counterstained with hematoxylin and dehydrated. Negative controls included the application of the same immunohistochemistry protocol to sections, except PBS was applied instead of the primary antibody.

Image analysis of APP positive cells

The method employed here was essentially the same as that described previously [1]. Each image was analyzed using image analysis software (ImageJ 1.50i, National Institutes of Health, Bethesda, MD, USA). Areas occupied by APP-immunoreactive products within the regions of interest were evaluated; the total area occupied by the outlined structures was measured in order to calculate the percentage of the area occupied by the immunoreactive products over the total outlined anatomical area in the image.

Behavioral phenotyping

All behavioral studies were performed blind to genotype. All behavioral experiments were conducted during the light phase. All behavioral tests were initiated at either 7 days or 28 days after TBI.

Spontaneous physical activity

The method employed here was essentially the same as that described previously [3], [4]. Mice were transferred to a familiar home cage (21×31×12 cm) and were video recorded for 3 h, beginning from 10:00 to 14:00. Movie data were analyzed using the CleverSys HomeCageScan system (CleverSys Inc., Reston, VA, USA), and spontaneous physical activities such as distance traveled, rearing, hanging, and stretching were evaluated.

Rotarod test

The rotarod apparatus (Ugo Basile, Monvalle VA, Italy) consisted of a rod 3 cm in diameter, rotating at 20 rpm. The time that the mouse remained on the rod was measured (a maximum of 120 s). Mice completed one session every day for 5 days (2 trials per session).

Eyeblink conditioning

Eyeblink conditioning procedures were essentially the same as previously described [3]. Under anesthetized conditions, four stainless steel wires (100 μm in diameter; A-M Systems, Sequim, WA, USA) were subcutaneously implanted under the left eyelid. Two wires were used to apply the unconditioned stimulus (US), and the remaining two wires were used to receive an electromyogram (EMG) signal from the musculus orbicularis oculi. A 352-ms tone (1 kHz, 80 dB) generated by a speaker was used as the conditioned stimulus (CS), and a 100-ms electrical shock (0.2–0.5 mA, 100-Hz) was used as the US. Each daily session consisted of 100 trials (10 trials of the CS alone and 90 trials of the CS and US paired together). In the present study, the CS and the US temporally overlapped and terminated simultaneously. Mice completed 7 days of these acquisition sessions. The EMG signals were analyzed the same way as previously described [3], [5], [6].

Statistical analysis

Statistical analyses were conducted using the Statistical Package for GraphPad Prism 6 (GraphPad Software Inc., La Jolla, CA, USA) to determine differences between groups. Specifically, two-way repeated measures analysis of variance (ANOVA) was used to analyze the data, followed by a post hoc Bonferroni test and unpaired t-tests (two-tailed). Significance was defined as p<0.05.
Subject areaNeuroscience
More specific subject areaAlzheimer׳s disease, immunohistochemistry, behavioral neuroscience
Type of dataGraph, figure, image
How data was acquiredBehavioral phenotyping (HomeCageScan, CleverSys Inc., Reston, VA; rotarod system (Ugo Basile, Monvalle VA, Italy); eyeblink conditioning system (A-M Systems, Sequim, WA, USA) and fluorescent microscope (ECLIPS Ci, Nikon, Tokyo, Japan).
Data formatRaw and analyzed
Experimental factors5- to 7-month-old homozygous triple-transgenic AD-model (3×Tg-AD) mice
Experimental features3×Tg-AD mouse were examined using behavioral and immunohistochemical methods following TBI or sham treatment
Data source locationMiki-cho, Kagawa, Japan and Sanuki-shi, Kagawa, Japan
Data accessibilityData is within this article
  6 in total

1.  Classical eyeblink conditioning in glutamate receptor subunit delta 2 mutant mice is impaired in the delay paradigm but not in the trace paradigm.

Authors:  Y Kishimoto; S Kawahara; M Suzuki; H Mori; M Mishina; Y Kirino
Journal:  Eur J Neurosci       Date:  2001-03       Impact factor: 3.386

2.  Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

Authors:  Salvatore Oddo; Antonella Caccamo; Jason D Shepherd; M Paul Murphy; Todd E Golde; Rakez Kayed; Raju Metherate; Mark P Mattson; Yama Akbari; Frank M LaFerla
Journal:  Neuron       Date:  2003-07-31       Impact factor: 17.173

3.  Increase in activity during calorie restriction requires Sirt1.

Authors:  Danica Chen; Andrew D Steele; Susan Lindquist; Leonard Guarente
Journal:  Science       Date:  2005-12-09       Impact factor: 47.728

4.  Presenilin 2 mutation accelerates the onset of impairment in trace eyeblink conditioning in a mouse model of Alzheimer's disease overexpressing human mutant amyloid precursor protein.

Authors:  Yasushi Kishimoto; Yutaka Kirino
Journal:  Neurosci Lett       Date:  2013-01-28       Impact factor: 3.046

5.  Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.

Authors:  Hajime Shishido; Yasushi Kishimoto; Nobuyuki Kawai; Yasunori Toyota; Masaki Ueno; Takashi Kubota; Yutaka Kirino; Takashi Tamiya
Journal:  Neurosci Lett       Date:  2016-06-29       Impact factor: 3.046

6.  Task-specific enhancement of hippocampus-dependent learning in mice deficient in monoacylglycerol lipase, the major hydrolyzing enzyme of the endocannabinoid 2-arachidonoylglycerol.

Authors:  Yasushi Kishimoto; Barbara Cagniard; Maya Yamazaki; Junko Nakayama; Kenji Sakimura; Yutaka Kirino; Masanobu Kano
Journal:  Front Behav Neurosci       Date:  2015-06-02       Impact factor: 3.558

  6 in total
  2 in total

Review 1.  Therapeutic Approach to Alzheimer's Disease: Current Treatments and New Perspectives.

Authors:  Teresa Pardo-Moreno; Anabel González-Acedo; Antonio Rivas-Domínguez; Victoria García-Morales; Francisco Jose García-Cozar; Juan Jose Ramos-Rodríguez; Lucía Melguizo-Rodríguez
Journal:  Pharmaceutics       Date:  2022-05-24       Impact factor: 6.525

Review 2.  Physical Activity and Alzheimer's Disease: A Narrative Review.

Authors:  Piotr Gronek; Stefan Balko; Joanna Gronek; Adam Zajac; Adam Maszczyk; Roman Celka; Agnieszka Doberska; Wojciech Czarny; Robert Podstawski; Cain C T Clark; Fang Yu
Journal:  Aging Dis       Date:  2019-12-01       Impact factor: 6.745

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.